LUTHERVILLE, Md., April 17, 2012 /PRNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) – a nonprofit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of drug diversion – today lauded the latest quarterly results achieved by the real-time, stop-sale system in Texas. Quarterly data released for 2012 by the National Precursor Log Exchange (NPLEx) shows electronic technology in the Lone Star State blocked the sale of more than 44,700 boxes of medicines containing pseudoephedrine (PSE) preventing more than 111,000 grams from potentially being diverted by meth criminals.
"In just three short months since full implementation, Texas' real-time, stop-sale technology is proving to be an irreplaceable resource for law enforcement officials and retailers in the battle against meth production and use," said Charles F. Cichon, executive director of the National Association of Drug Diversion Investigators (NADDI). "NPLEx allows retailers - using technology similar to a credit card transaction - to stop illegal purchases of cold and allergy medications right at the sales counter. Data collected by the system is also provided to police officers in real time - providing them with an invaluable tool to track down meth offenders. The quarterly numbers offer ample proof that NPLEx is successfully stopping illegal sales, while allowing legal ones."
The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies, pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.
SOURCE National Association of Drug Diversion Investigators